Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Highlights
ZTS logo

Zoetis Achieves 1% Revenue Growth and Margin Expansion Post-Divestiture

ZTS10-QFiling Date: 11/4/2025
Zoetis Inc.
Description

What this story covers

Zoetis reported Q3 revenue of $2.4B, up 1%, with companion animals driving 69% of sales amid MFA divestiture impacts. Net income rose 6% to $721M, margins improved to 71.5%. Strong liquidity at $2.08B cash supports repurchases and R&D, navigating trade risks and regulatory uncertainties.

Story snapshot

CompanyZoetis Inc.
TickerZTS
VariantStandard detailed
Duration11:57
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001555280-25-000274

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in